Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Hangzhou Tigermed Consulting Co., Ltd. has scheduled a Board meeting for August 28, 2024, to review and approve its financial performance for the first half of the year and to consider the declaration and payment of an interim dividend. This announcement underscores the company’s commitment to transparency and shareholder engagement. The upcoming meeting is a key event for investors, as it will provide insights into the company’s earnings and potential returns in the form of dividends.
For further insights into HK:3347 stock, check out TipRanks’ Stock Analysis page.
